TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11175236

Group type: EXPERIMENTAL
Intervention: Chemically-heated HME (Thermax HCH Filter)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional HME (Humid-Vent 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 50
Study: 9747640

Group type: EXPERIMENTAL
Intervention: Pituitary irradiation for diabetic retinopathy
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control group (WESDR)
Number of subjects: 167
Study: 7530437

Group type: EXPERIMENTAL
Intervention: Combination of alpha fetoprotein and free beta human chorionic gonadotropin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unconjugated oestriol and pregnancy associated plasma protein A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First trimester screening
Number of subjects: 0
Study: 2902114

Group type: EXPERIMENTAL
Intervention: Levocabastine (0.5 mg/ml, one drop twice a day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: COMPARATOR
Intervention: Screening test (no medication)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Levocabastine
Number of subjects: 11
Study: 29379143

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: White wine
Number of subjects: 224

Group type: COMPARATOR
Intervention: Water
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Wine (combined)
Number of subjects: 224
Study: 27784379

Group type: EXPERIMENTAL
Intervention: decitabine + HAG pre‐excitation regimen
Number of subjects: 50

Group type: COMPARATOR
Intervention: '3+7' regimen
Number of subjects: 50
Study: 25322606

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg) over 15 minutes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Propofol (2 mg/kg) intravenous injection
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups (Dexmedetomidine and Propofol)
Number of subjects: 44
Study: 23464842

Group type: EXPERIMENTAL
Intervention: Low stress condition (n=20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: High stress condition (n=21)
Number of subjects: 41
Study: 20428741

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 ug)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intramuscular oxytocin (10 IU)
Number of subjects: 200
Study: 18275768

Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids and immunosuppressive drugs (cyclophosphamide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 0
Study: 15842575

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 794

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 794
Study: 12136891

Group type: EXPERIMENTAL
Intervention: Custom manufactured rigid foot orthoses under podiatry supervision
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (foot orthoses prescribed under normal medical care)
Number of subjects: 98
Study: 10544862

Group type: EXPERIMENTAL
Intervention: Soy protein-based formula (SOY)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Soy protein-based formula with added nucleotide (SOYN)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Mixed feeding (MF)
Number of subjects: 213
Study: 7837822

Group type: EXPERIMENTAL
Intervention: Educational memorandum alone or combined with feedback regarding individual prescribing behavior
Number of subjects: 63
Study: 2123115

Group type: EXPERIMENTAL
Intervention: 3.75 mg leuprorelin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 7.5 mg leuprorelin
Number of subjects: 12
Study: 872745

Group type: EXPERIMENTAL
Intervention: Primary multiple enterostomies
Number of subjects: 30

Group type: COMPARATOR
Intervention: Proctocolectomy in one stage
Number of subjects: 30
Study: 30964852

Group type: EXPERIMENTAL
Intervention: Ambient noise level 60 dB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ambient noise level 75 dB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ambient noise level 80 dB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subsequent intubation attempts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiological heart rate monitoring
Number of subjects: 0
Study: 30652777

Group type: EXPERIMENTAL
Intervention: Brief Group Intervention (BGI) with four group sessions, weekly meetings
Number of subjects: 180

Group type: COMPARATOR
Intervention: Information leaflet about alcohol consumption
Number of subjects: 180
Study: 27679533

Group type: EXPERIMENTAL
Intervention: FAST‐MAG clinical trial (Field Administration of Stroke Therapy‐Magnesium)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Very elderly population
Number of subjects: 490
Study: 24523488

Group type: EXPERIMENTAL
Intervention: Dose-dilution protocol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test-retest protocol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doubly labeled water (DLW) method
Number of subjects: 0
Study: 22264468

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle weight loss intervention
Number of subjects: 2739

Group type: COMPARATOR
Intervention: Diabetes support and education
Number of subjects: 2739

Group type: EXPERIMENTAL
Intervention: Weight loss (each kg lost)
Number of subjects: 2739

Group type: EXPERIMENTAL
Intervention: Weight loss (5% to 10%)
Number of subjects: 2739
Study: 20859046

Group type: EXPERIMENTAL
Intervention: Vinyl bags used for resuscitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional drying under radiant warmer (Control)
Number of subjects: 60
Study: 18180167

Group type: EXPERIMENTAL
Intervention: Surveyed after consultation with specially trained midwives
Number of subjects: 300

Group type: COMPARATOR
Intervention: Surveyed before consultation with specially trained midwives
Number of subjects: 300
Study: 15860237

Group type: EXPERIMENTAL
Intervention: Pioglitazone (n=13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Glibenclamide (n=14)
Number of subjects: 27
Study: 14564193

Group type: EXPERIMENTAL
Intervention: Increased dose of peritoneal small molecule clearance delivered by chronic ambulatory peritoneal dialysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical assessment of dialysis adequacy, preservation of residual renal function, and optimization of salt and water removal
Number of subjects: 0
Study: 10828859

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy and autologous stem cell transplantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9058342

Group type: EXPERIMENTAL
Intervention: 400 mg itraconazole (one-day monthly prophylaxis for six months)
Number of subjects: 57

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 57
Study: 8375881

Group type: EXPERIMENTAL
Intervention: Iron supplementation (40 mg elemental iron/day) for six months
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sugar placebo
Number of subjects: 170
Study: 3091138

Group type: EXPERIMENTAL
Intervention: Oestrogen (160 mg polyestradiol phosphate intramuscularly every month for the first three months, then 80 mg monthly, plus ethinyloestradiol 1 mg by mouth daily for the first two weeks, then 150 micrograms daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 100
Study: 29703446

Group type: EXPERIMENTAL
Intervention: Prism adaptation plus methylphenidate (MP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prism adaptation plus placebo
Number of subjects: 24
Study: 26318636

Group type: EXPERIMENTAL
Intervention: 3D‐LPNSSAC
Number of subjects: 90

Group type: COMPARATOR
Intervention: 2D‐LPN
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 25066223

Group type: EXPERIMENTAL
Intervention: MCT + treatment as usual (TAU)
Number of subjects: 154

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: MCT + TAU
Number of subjects: 154
Study: 22762533

Group type: EXPERIMENTAL
Intervention: Any bleeding during the first 20 weeks of pregnancy
Number of subjects: 3431

Group type: EXPERIMENTAL
Intervention: Bleeding episode of five or more consecutive days
Number of subjects: 3431

Group type: EXPERIMENTAL
Intervention: Multiple episodes of bleeding
Number of subjects: 3431
Study: 19939373

Group type: EXPERIMENTAL
Intervention: High hyaluronic acid (HA) transfer medium, n = 199
Number of subjects: 425

Group type: COMPARATOR
Intervention: Low hyaluronic acid (HA) transfer medium, n = 226
Number of subjects: 425
Study: 18540734

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for pain (P)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation and emotion regulation therapy (M)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Education-only group (E)
Number of subjects: 144
Study: 15846228

Group type: EXPERIMENTAL
Intervention: Micronized estradiol (E2) 1 mg/day
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: E2 1 mg/day + MPA 10 mg/day
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 10 mg/day
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Micronized progesterone (P4) 300 mg/day
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Norethindrone (NET) 1 mg/day
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (1000 mg of calcium and 400 IU of vitamin D/day)
Number of subjects: 132
Study: 11427217

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (50 mg/day)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Beta-carotene (20 mg/day)
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29133
Study: 9517683

Group type: EXPERIMENTAL
Intervention: Prilocaine-phenylephrine
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Bupivacaine-phenylephrine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Tetracaine-adrenaline-cocaine (TAC)
Number of subjects: 180
Study: 7752832

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ) therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anthracyclines (ANT) without CoQ therapy
Number of subjects: 20
Study: 3281412

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg daily for the first 3 months
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Placebo treatment for the first 3 months
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: Metoprolol (early treatment, ≤ 8 hours after onset of pain)
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Placebo (early treatment, ≤ 8 hours after onset of pain)
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: Metoprolol (late treatment, > 8 hours after onset of pain)
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Placebo (late treatment, > 8 hours after onset of pain)
Number of subjects: 1395
Study: 8181329

Group type: EXPERIMENTAL
Intervention: Cough (30 coughs over a 10-min period)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Forced expiration (30 forced expirations over a 10-min period)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 14740680

Group type: EXPERIMENTAL
Intervention: Surgical therapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 26
Study: 30326790

Group type: EXPERIMENTAL
Intervention: Dynamic warm-up
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Resistance-band warm-up
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 23
Study: 28437520

Group type: EXPERIMENTAL
Intervention: Caffeine citrate
Number of subjects: 920

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 920
Study: 25928009

Group type: EXPERIMENTAL
Intervention: Integrated maternal health intervention (training and deployment of Community Based Skilled Birth Attendants)
Number of subjects: 3000
Study: 23706048

Group type: EXPERIMENTAL
Intervention: Sustained low-efficiency dialysis (SLED)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Continuous veno-venous hemofiltration (CVVH)
Number of subjects: 10
Study: 20102772

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (70% of peak oxygen uptake)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Moderate-intensity aerobic exercise (50% of peak oxygen uptake)
Number of subjects: 9
Study: 20209976

Group type: EXPERIMENTAL
Intervention: Ginger-partitioned moxibustion
Number of subjects: 209

Group type: COMPARATOR
Intervention: Medication (Yueyueshu Granules)
Number of subjects: 209
Study: 17549294

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5-60 mg, oral, twice-daily)
Number of subjects: 1343

Group type: COMPARATOR
Intervention: Enoxaparin (40 mg once daily before THR, 30 mg bid after TKR)
Number of subjects: 1343

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 1343

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5-20 mg)
Number of subjects: 1343
Study: 15302725

Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training (IMT) at 80% of maximal effort (group 1)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low-intensity inspiratory muscle training (IMT) at 20% of maximal effort (group 2)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (group 3)
Number of subjects: 29
Study: 11477494

Group type: EXPERIMENTAL
Intervention: Exercise training (8 week supervised program, aerobic exercise at 75% VO(2) peak, 45 min, twice a week; intermittent exercise once a week)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 16
Study: 9495222

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg every 8 hours) with zidovudine (AZT)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg every 8 hours) with didanosine (ddI) administered sequentially (2 hours before ganciclovir)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg every 8 hours) with didanosine (ddI) administered simultaneously
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg every 8 hours) with probenecid
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg every 8 hours) administered 2 hours after didanosine (ddI)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oral ganciclovir (1000 mg every 8 hours) with no coadministration
Number of subjects: 26
Study: 8053737

Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 15

Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 15
Study: 2902319

Group type: EXPERIMENTAL
Intervention: Clonidine (0.1 mg/m2 by mouth, nightly for 6 months)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (for 6 months)
Number of subjects: 12
Study: 29939961

Group type: EXPERIMENTAL
Intervention: Interoceptive Exposure (IE) therapy
Number of subjects: 126

Group type: COMPARATOR
Intervention: Relaxation Therapy (RT)
Number of subjects: 126
Study: 28614188

Group type: EXPERIMENTAL
Intervention: Sham opioid solution (NaCl) with verbal instruction that it reduces pain and improves physical capacity
Number of subjects: 48

Group type: COMPARATOR
Intervention: Inactive solution (NaCl) presented as an effective treatment
Number of subjects: 48
Study: 25408218

Group type: EXPERIMENTAL
Intervention: Healthy Brain Ageing Cognitive Training (HBA‐CT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment-as-usual control
Number of subjects: 64
Study: 23347341

Group type: EXPERIMENTAL
Intervention: AndroGel 1% 5 g, 7.5 g, or 10 g once daily for 6 months (Study 1)
Number of subjects: 283

Group type: COMPARATOR
Intervention: AndroGel 1% 7.5 g once daily titrated as needed (Study 2)
Number of subjects: 283

Group type: COMPARATOR
Intervention: AndroGel 1% 5 g once daily (Study 3)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Postmarketing data from 2001 to 2011
Number of subjects: 283
Study: 21185967

Group type: EXPERIMENTAL
Intervention: Breastfeeding (BF)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Mixed feeding (MF)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Formula feeding (FF)
Number of subjects: 450
Study: 19296208

Group type: EXPERIMENTAL
Intervention: Nasal powder formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial nasal liquid spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sublingual tablet
Number of subjects: 0
Study: 18031872

Group type: EXPERIMENTAL
Intervention: HBsAg with AS02B adjuvant candidate vaccine plus lamivudine daily for 52 weeks
Number of subjects: 195

Group type: COMPARATOR
Intervention: lamivudine daily alone
Number of subjects: 195
Study: 14727216

Group type: EXPERIMENTAL
Intervention: Indinavir (800 mg) and Ritonavir (100 mg) twice a day with Rifampin (300 mg every day for 4 days)
Number of subjects: 6
Study: 11383979

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zopiclone 15 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9629648

Group type: EXPERIMENTAL
Intervention: Group sequential method based on the sequential conditional probability ratio test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group sequential method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential test
Number of subjects: 0
Study: 8067842

Group type: EXPERIMENTAL
Intervention: Heparin-coated membrane oxygenators (100 IU/kg heparin)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Noncoated control membrane oxygenators (300 IU/kg heparin)
Number of subjects: 30
Study: 2646416

Group type: EXPERIMENTAL
Intervention: Surfactant therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 19
Study: 31489293

Group type: EXPERIMENTAL
Intervention: Cisplatin 40 mg/m2 (weekly)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m2 (3 weekly)
Number of subjects: 60
Study: 25908501

Group type: EXPERIMENTAL
Intervention: Therapeutic massage (effleurage, kneading, and trigger point therapy) for 10 minutes, four times per week for 4 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 10
Study: 26228408

Group type: EXPERIMENTAL
Intervention: CBT group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: iCBT group
Number of subjects: 60
Study: 23189997

Group type: EXPERIMENTAL
Intervention: Lingualised occlusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bilaterally balanced occlusion
Number of subjects: 30
Study: 21275915

Group type: EXPERIMENTAL
Intervention: Anemia
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Zinc deficiency
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Vitamin B-12 deficiency
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Folate deficiency
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Ascaris infestation
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Seasonal variation
Number of subjects: 740
Study: 20011888

Group type: EXPERIMENTAL
Intervention: Electroanalgesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16952489

Group type: EXPERIMENTAL
Intervention: Tariquidar (150 mg over 30 minutes)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 15589636

Group type: EXPERIMENTAL
Intervention: Invasive management
Number of subjects: 188

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 188
Study: 11418151

Group type: EXPERIMENTAL
Intervention: Cases containing threats from the patient or their relatives (n=630)
Number of subjects: 1260

Group type: COMPARATOR
Intervention: No threats (control group, n=630)
Number of subjects: 1260
Study: 9349914

Group type: EXPERIMENTAL
Intervention: Recruitment data from clinical studies
Number of subjects: 1323
Study: 8406149

Group type: EXPERIMENTAL
Intervention: Liquid fibre (250 ml)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (250 ml)
Number of subjects: 10
Study: 3779341

Group type: EXPERIMENTAL
Intervention: Wet suit
Number of subjects: 16

Group type: COMPARATOR
Intervention: No wet suit
Number of subjects: 16
Study: 31629347

Group type: EXPERIMENTAL
Intervention: 4 days of blueberries (4DAY)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2 days of placebo followed by 2 days of blueberries (2DAY)
Number of subjects: 14
Study: 30021691

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of montelukast/levocetirizine 10/5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separate tablets of montelukast and levocetirizine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 27180088

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interim methadone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient navigation plus medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual (ETAU)
Number of subjects: 0
Study: 25223180

Group type: EXPERIMENTAL
Intervention: Radix Astragali and Rehmanniae Radix combined with glucocorticoid (GC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Western medicine (mainly by GC and cyclophosphamide)
Number of subjects: 52
Study: 22102323

Group type: EXPERIMENTAL
Intervention: Enhanced Dissemination Strategy (EDS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Basic Dissemination Strategy (BDS)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: GSS use overall
Number of subjects: 68
Study: 19284663

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (13 group sessions over 1 year, complemented by 3 individual home visits, tailored to literacy needs and cultural preferences, delivered in Spanish)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 17343767

Group type: EXPERIMENTAL
Intervention: Advice to increase fatty fish intake
Number of subjects: 5147

Group type: EXPERIMENTAL
Intervention: Advice to eat oily fish or take fish oil
Number of subjects: 5147

Group type: EXPERIMENTAL
Intervention: Advice to eat more fruit and vegetables
Number of subjects: 5147
Study: 15525654

Group type: EXPERIMENTAL
Intervention: Occupational therapist-led assessment
Number of subjects: 321

Group type: COMPARATOR
Intervention: Social worker-led assessment
Number of subjects: 321
Study: 11939870

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 75